" class="no-js "lang="en-US"> China Archives - Medtech Alert
Sunday, June 16, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

CANbridge Announces Marketing Approval of CAN108 in China for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]

BeiGene Receives New Approvals for BRUKINSA (zanubrutinib) in China

BeiGene, a global biotechnology company, has announced the China National Medical Products Administration (NMPA) approved […]

Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]

CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment

CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]

TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China

TaiGen Biotechnology Company announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical […]

Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration

Eisai and Biogen announced today that the Biologics License Application (BLA) for lecanemab, an investigational […]

Neurophth Completes Patient Enrollment for Phase III clinical trial for the Gene Therapy treatment of LHON

Neurophth Therapeutics announced today that the last patient has been enrolled in the Phase III […]

Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib

Takeda has today announced that it has entered into an exclusive licensing agreement with HUTCHMED […]

First Patient Dosed in CANbridge Pharmaceuticals Trial for the Treatment of Gaucher Disease in China

CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]

OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India

OnQuality Pharmaceuticals, a targeted oncology supportive therapy company developing innovative medications to address the quality […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more